NCT00154271View on ClinicalTrials.gov

Effects of Blood Pressure Reduction on High Sensitivity C-Reactive Protein (hsCRP)

PHASE4CompletedINTERVENTIONAL

Enrollment

1,677

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions

Hypertension

Interventions

DRUG

Valsartan, Valsartan HCT

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY